Sort
16,300 grants matching “fatty liver disease”
Starvation resistance and resilience of metabolic dysfunction in cavefish
$2,475,000Nicolas Rohner · Stowers Institute For Medical Research · DP2 · FY2020 · AG
Regulation of hepatic and systemic immune responses
$2,472,718Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,467,924M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
Competing Renewal P01
$2,465,405Vishwa Deep Dixit · Yale University · P01 · FY2023 · AG
Competing Renewal P01
$2,459,384Vishwa Deep Dixit · Yale University · P01 · FY2024 · AG
Endocannabinoids And Energy Homeostasis
$2,457,470George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Triglycerides, Diabetes and Cardiovascular Disease
$2,453,240Karin E. Bornfeldt · University Of Washington · P01 · FY2024 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,450,733Kodi S Ravichandran · University Of Virginia · P01 · FY2020 · HL
Xenobiotic receptors
$2,445,645Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2021 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2022 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2023 · HL
New Approaches to Reduce Residual Cardiovascular Risk
$2,434,908Jay D Horton · Ut Southwestern Medical Center · P01 · FY2024 · HL
General Clinical Research Center
$2,428,731Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2009 · RR
Xenobiotic receptors
$2,428,351Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,425,096Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2019 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,421,934Kodi S Ravichandran · University Of Virginia · P01 · FY2019 · HL
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,418,566M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2024 · HL
DETECTION AND MODELS OF TOXICANT EXPOSURE
$2,415,449Robert H Tukey · University Of California, San Diego · P42 · FY2019 · ES
DETECTION AND MODELS OF TOXICANT EXPOSURE
$2,415,449Robert H Tukey · University Of California, San Diego · P42 · FY2018 · ES
Competing Renewal P01
$2,410,195Vishwa Deep Dixit · Yale University · P01 · FY2025 · AG
Triglycerides, Diabetes and Cardiovascular Disease
$2,409,622Karin E. Bornfeldt · University Of Washington · P01 · FY2020 · HL
Molecular mechanisms and pathways of novel genomic loci regulating plasma lipids
$2,400,000Daniel James Rader · University Of Pennsylvania · RC2 · FY2009 · HL
Role of hypernutrition and metabolic stress in non-alcoholic steatohepatitis (NASH) driven hepatocellular carcinoma (HCC)
$2,397,277Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · CA
Triglycerides, Diabetes and Cardiovascular Disease
$2,390,187Karin E. Bornfeldt · University Of Washington · P01 · FY2023 · HL